Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
INFI [NASD]
Infinity Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-3.05 Insider Own0.20% Shs Outstand48.58M Perf Week-4.08%
Market Cap617.45M Forward P/E- EPS next Y-2.84 Insider Trans-47.53% Shs Float47.62M Perf Month-6.13%
Income-147.20M PEG- EPS next Q-0.88 Inst Own97.70% Short Float8.62% Perf Quarter31.30%
Sales- P/S- EPS this Y-55.30% Inst Trans0.00% Short Ratio4.27 Perf Half Y27.87%
Book/sh2.85 P/B4.46 EPS next Y16.50% ROA-68.70% Target Price18.90 Perf Year-8.43%
Cash/sh2.90 P/C4.38 EPS next 5Y3.00% ROE-79.20% 52W Range8.40 - 18.35 Perf YTD-7.97%
Dividend- P/FCF- EPS past 5Y-33.80% ROI- 52W High-30.74% Beta1.13
Dividend %- Quick Ratio6.00 Sales past 5Y- Gross Margin- 52W Low51.31% ATR0.75
Employees180 Current Ratio6.00 Sales Q/Q- Oper. Margin- RSI (14)47.38 Volatility5.73% 5.91%
OptionableYes Debt/Eq0.00 EPS Q/Q-14.70% Profit Margin- Rel Volume0.37 Prev Close13.00
ShortableYes LT Debt/Eq0.00 EarningsNov 03 BMO Payout- Avg Volume977.49K Price12.71
Recom2.10 SMA20-4.28% SMA50-2.66% SMA2006.35% Volume362,454 Change-2.23%
20-Oct-14Resumed Stifel Hold
06-Mar-13Reiterated Stifel Buy $39 → $50
06-Mar-13Reiterated RBC Capital Mkts Outperform $38 → $55
21-Nov-12Initiated RBC Capital Mkts Outperform $28
24-Aug-12Initiated Stifel Nicolaus Hold
05-Jan-12Initiated Rodman & Renshaw Mkt Perform
16-Apr-09Downgrade Roth Capital Hold → Sell $6 → $4
15-Apr-09Downgrade Rodman & Renshaw Mkt Outperform → Mkt Perform
11-Dec-08Downgrade Roth Capital Neutral → Hold
20-Nov-08Reiterated Rodman & Renshaw Mkt Outperform
31-Oct-08Upgrade Susquehanna Financial Neutral → Positive
31-Oct-08Upgrade Roth Capital Hold → Buy $8 → $6
31-Jul-08Downgrade Roth Capital Buy → Hold $11 → $8
06-Jun-08Upgrade Rodman & Renshaw Mkt Perform → Mkt Outperform $13
15-Jan-08Initiated Roth Capital Buy $11
07-Dec-07Initiated Susquehanna Financial Neutral
03-Aug-07Upgrade Robert W. Baird Neutral → Outperform $15 → $16
12-Jul-07Initiated Jefferies & Co Buy $15
30-Jan-07Initiated Robert W. Baird Neutral $15
17-Oct-14 04:00PM  Infinity Pharmaceuticals' Duvelisib Fails in Mid-Stage Study Zacks
16-Oct-14 07:47AM  INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and E EDGAR Online
07:35AM  Infinity Reports Topline Data from Phase 2a Exploratory Study of Duvelisib in Patients with Mild, Allergic Asthma Business Wire
26-Sep-14 08:01AM  INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online
22-Sep-14 12:59PM  3 Partnerships Pushing The Pharmaceutical Sector Forward Benzinga
11-Sep-14 07:59AM  The Zacks Analyst Blog Highlights: AbbVie, Infinity Pharmaceuticals, Keryx Biopharmaceuticals, Gilead and Amgen Zacks
10-Sep-14 08:30PM  Stock Trading Ideas for 9/10/12 Yahoo Finance Blogs
10:17AM  Biotech Stock Roundup: AbbVie Ties Up with Infinity, Keryx Slips on FDA Approval Zacks
09-Sep-14 06:48AM  Infinity Pharmaceuticals (INFI) Soars: Stock Rises 7.1% Zacks
08-Sep-14 01:02PM  Pharmacyclics Price Target Cut On Higher Spending at Investor's Business Daily +7.05%
04-Sep-14 04:10PM  Will AbbVie's $805 Million Agreement for Duvelisib Pay Off? Zacks -8.90%
03-Sep-14 06:36PM  Infinity, AbbVie team on drug Investor's Business Daily +44.05%
06:14PM  Nasdaq stocks posting largest percentage increases AP
06:11PM  Infinity Pharma (INFI) Shares Skyrocket on Cancer Drug Partnership Zacks
04:32PM  [video] Stocks Close Mixed on Apple, Tesla Chooses Nevada for 'Gigafactory' at TheStreet
02:10PM  Is Infinity Fully Valued Now, or Is More Upside Left? at 24/7 Wall St.
01:35PM  [video] Infinity Pharma teams up with AbbVie for cancer drug at CNBC
01:20PM  Infinity Pharma JoinsAbbVie On Blood Cancer Drug at Investor's Business Daily
01:10PM  Infinity Up Big on AbbVie Deal, Small Pharma in Focus StockTwits
10:15AM  Why Infinity Pharmaceuticals (INFI) Stock Is Soaring Today at TheStreet
09:08AM  Stock Futures Up And Climbing; Baidu Heads China Stock Rally at Investor's Business Daily
08:51AM  Toll Brothers builds up profits; Netflix nabs another TV series; Concur for sale? Hot Stock Minute
08:30AM  Infinity Pharmaceuticals Inc and AbbVie to Discuss Strategic Collaboration In Oncology Call scheduled for 8:30 am ET today CCBN
07:49AM  INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financia EDGAR Online
07:47AM  [$$] Infinity, AbbVie to Develop Cancer Treatment at The Wall Street Journal
07:37AM  Infinity Pharmaceuticals shares soar after AbbVie collaboration at MarketWatch
06:57AM  Infinity Pharma Snags Abbvie for Blood Cancer Drug Partnership at TheStreet
06:45AM  Infinity And AbbVie Announce Global Strategic Collaboration To Develop And Commercialize Duvelisib (IPI-145) In Oncology PR Newswire
06:45AM  Infinity and AbbVie Announce Global Strategic Collaboration to Develop and Commercialize Duvelisib (IPI-145) In Oncology Business Wire
06:30AM  Infinity Enters into Master Clinical Supply Agreement and Material Transfer Agreement with Roche Business Wire
27-Aug-14 08:00AM  Infinity to Participate in Two Conferences in September Business Wire
25-Aug-14 11:41AM  Markets Open Higher; Burger King In Talks To Buy Tim Hortons Benzinga
19-Aug-14 01:04PM  INFINITY PHARMACEUTICALS, INC. Financials EDGAR Online Financials
11-Aug-14 08:30AM  INFINITY PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
06-Aug-14 11:35AM  Traders see no going back for Infinity optionMONSTER +7.82%
07:47AM  3 Stocks Under $10 Making Big Moves at TheStreet
05-Aug-14 08:15AM  INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement EDGAR Online +6.74%
08:00AM  Infinity Reports Second Quarter 2014 Financial Results and Provides Company Update Business Wire
07:07AM  Q2 2014 Infinity Pharmaceuticals, Inc. Earnings Release - Before Market Open CCBN
04-Aug-14 04:43PM  INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financia EDGAR Online
04:05PM  Infinity Amends PI3K-Delta, Gamma Agreement with Millennium Business Wire
24-Jul-14 08:00AM  Infinity Announces the Date of Its Second Quarter 2014 Financial Results Conference Call and Webcast Business Wire
22-Jul-14 08:21AM  Infinity to Participate in the BMO Capital Markets 3RD Annual Biotech Corporate Access Day Business Wire
07-Jul-14 02:54PM  3 Small-Cap Biotechs That Institutions Are Loving Benzinga -5.84%
01-Jul-14 03:25PM  Gilead Sciences Inc.'s Upcoming Catalyst(s) at Motley Fool
19-Jun-14 04:08PM  INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
16-Jun-14 08:47AM  Five Biotech Stocks With Big Potential And Billionaire Believers at Forbes
03-Jun-14 08:00AM  Infinity to Present at the Goldman Sachs 35th Annual Global Healthcare Conference Business Wire
27-May-14 08:00AM  Infinity to Participate in Four Conferences in June Business Wire +5.53%
15-May-14 08:35AM  Gilead study 'alarming,' says Stifel at theflyonthewall.com -5.10%
08-May-14 04:20PM  Infinity Pharma Down on Wider-than-Expected Loss Zacks
07-May-14 07:52AM  Infinity Pharmaceuticals upgraded to Buy from Hold at Jefferies at theflyonthewall.com
06-May-14 04:30PM  Infinity Pharmaceuticals, Inc. Earnings Call scheduled for 4:30 pm ET today CCBN
04:19PM  INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement EDGAR Online
04:00PM  Infinity Reports First Quarter 2014 Financial Results and Provides Company Update Business Wire
03:57PM  INFINITY PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
07:07AM  Q1 2014 Infinity Pharmaceuticals, Inc. Earnings Release - After Market Close CCBN
30-Apr-14 08:00AM  Infinity to Participate in 3 Upcoming Conferences Business Wire
28-Apr-14 09:50AM  Drugs That Disappointed Investors In 2013: Infinity's IPI-145 at Seeking Alpha
24-Apr-14 08:00AM  Infinity Announces the Date of Its First Quarter 2014 Financial Results Conference Call and Webcast Business Wire
11-Mar-14 04:07PM  Infinity Appoints Two Experienced Life Science Leaders to Its Board of Directors Business Wire
10-Mar-14 05:28PM  INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements an EDGAR Online
04:00PM  Infinity Appoints Two Experienced Life Science Leaders to Its Board of Directors Business Wire
03-Mar-14 08:00AM  Infinity to Present at the Upcoming Bernstein Emerging Biotech Conference Business Wire
26-Feb-14 10:20AM  Infinity Pharma Rises on Narrower-than-Expected Loss Zacks
06:30AM  Infinity Pharmaceuticals (INFI) Jumps: Stock Adds 15.5% in Session Zacks
25-Feb-14 01:19PM  Why Infinity Pharmaceuticals Inc. Shares Jumped at Motley Fool +15.52%
12:05PM  Infinity Pharmaceuticals' CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
10:14AM  Show of support for Infinity Pharma optionMONSTER
08:30AM  Infinity Pharmaceuticals, Inc. Earnings Call scheduled for 8:30 am ET today CCBN
08:12AM  INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations EDGAR Online
08:00AM  Infinity Provides Company Update and Reports Full-Year 2013 Financial Results Business Wire
07:51AM  INFINITY PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report EDGAR Online
07:07AM  Q4 2013 Infinity Pharmaceuticals, Inc. Earnings Release - Before Market Open CCBN
19-Feb-14 08:00AM  Infinity to Participate in 3 Upcoming Conferences Business Wire
11-Feb-14 08:00AM  Infinity Announces the Date of Its Full-Year 2013 Financial Results Conference Call and Webcast Business Wire
10-Feb-14 05:01PM  INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Temporary Suspension of Trading Under Registrant's Employee Benefi EDGAR Online +5.35%
04-Feb-14 08:16AM  INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial EDGAR Online
08:00AM  Infinity Announces Promotion of David A. Roth to Chief Medical Officer Business Wire
23-Jan-14 04:03PM  Infinity reports Phase 1 data of IPI-145 clinically active in patients at theflyonthewall.com
Infinity Pharmaceuticals, Inc., a drug discovery and development company, focuses on discovering, developing, and delivering medicines to people with difficult-to-treat diseases. Its lead product candidate includes IPI-145, an oral inhibitor of Class I delta and gamma isoforms of phosphoinositide-3-kinase (PI3K) for the treatment of hematologic malignancies and inflammatory diseases. The company is conducting DUOTM, a randomized, monotherapy Phase 3 study of IPI-145 in patients with relapsed/refractory chronic lymphocytic leukemia; an ongoing Phase 1 dose-escalation study to evaluate the safety, pharmacokinetics, and clinical activity of IPI-145 in patients with advanced hematologic malignancies; a Phase 2 study to evaluate the efficacy, safety, and pharmacokinetics of IPI-145 in patients with rheumatoid arthritis; and a Phase 2a trial of IPI-145 in patients with mild allergic asthma, as well as completed a Phase 1 trial of IPI-145 in healthy adult subjects. It also develops IPI-443, an oral inhibitor of PI3K-delta and gamma; and IPI-940, an inhibitor of fatty acid amide hydrolase. The company has strategic collaboration with AbbVie Inc. to develop and commercialize duvelisib (IPI-145) in oncology. Infinity Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
EVNIN ANTHONY BDirectorOct 03Option Exercise12.5624,500307,76591,900Oct 06 04:06 PM
EVNIN ANTHONY BDirectorSep 30Sale13.56112,4511,525,2290Oct 02 04:05 PM
Palombella Vito J.Chief Scientific OfficerSep 03Option Exercise2.049,47219,3239,472Sep 05 04:05 PM
Palombella Vito J.Chief Scientific OfficerSep 03Sale15.399,472145,7740Sep 05 04:05 PM
Palombella Vito J.Chief Scientific OfficerJul 01Sale12.8787911,3130Jul 02 06:20 PM
SELBY NORMAN CDirectorMar 06Option Exercise8.872,50022,17510,000Mar 10 05:26 PM
Palombella Vito J.Chief Scientific OfficerFeb 25Option Exercise2.044,7369,6614,736Feb 27 04:05 PM
Palombella Vito J.Chief Scientific OfficerFeb 25Sale15.004,73671,0400Feb 27 04:05 PM
Palombella Vito J.Chief Scientific OfficerJan 02Sale13.5275310,1810Jan 06 04:30 PM
EVNIN ANTHONY BDirectorDec 02Sale14.5617,756258,527112,451Dec 04 04:30 PM
EVNIN ANTHONY BDirectorNov 27Sale14.561,20017,472130,207Nov 27 04:40 PM
EVNIN ANTHONY BDirectorNov 26Sale14.72138,9612,045,506131,407Nov 27 04:40 PM
EVNIN ANTHONY BDirectorNov 25Sale15.4023,703365,026270,368Nov 27 04:40 PM